Sunday, 8 September 2013

Design Of Novel Anti-Influenza Drugs That Circumvent Oseltamivir Resistance: A Critical Perspective | Full-text OMICS Publishing Group

Design Of Novel Anti-Influenza Drugs That Circumvent Oseltamivir Resistance: A Critical Perspective | Full-text OMICS Publishing Group:

'via Blog this'

No comments:

Post a Comment